US2022196646A1PendingUtilityA1

Method for manufacturing protein bioelectronic devices

Assignee: UNIV ARIZONA STATEPriority: Dec 18, 2020Filed: Dec 16, 2021Published: Jun 23, 2022
Est. expiryDec 18, 2040(~14.4 yrs left)· nominal 20-yr term from priority
C12Q 1/005C12Q 1/48G01N 2035/00168G01N 33/5438C12Q 1/6869G01N 2333/9125G01N 27/04
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides devices, systems, and methods related to protein bioelectronics. In particular, the present disclosure provides devices, systems, and methods for forming electrical contacts to a protein with high yield, which facilitates the manufacture of analytical devices to detect and measure the electrical characteristics corresponding to protein function.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of manufacturing a device for direct measurement of protein activity, the method comprising:
 combining a first and second electrode with a protein-of-interest to form an electrical connection between the electrodes, wherein the first and second electrodes comprise surfaces chemically modified with a linker molecule, and wherein the protein-of-interest comprises at least one non-canonical amino acid;   wherein applying a voltage bias to the electrodes produces current flow through the protein-of-interest.   
     
     
         2 . The method of  claim 1 , wherein fluctuations in activity of the protein-of-interest correspond to fluctuations in current. 
     
     
         3 . The method of  claim 1 , wherein the surfaces of the first and second electrodes are chemically modified with at least one thiolated biotin linker molecule. 
     
     
         4 . The method of  claim 1 , wherein the at least one non-canonical amino acid comprises biotin or a derivative thereof. 
     
     
         5 . The method of  claim 4 , wherein the at least one non-canonical amino acid is biocytin or a derivative thereof. 
     
     
         6 . The method of  claim 4 , wherein the protein-of-interest comprises two biocytin non-canonical amino acids or derivatives thereof. 
     
     
         7 . The method of  claim 1 , wherein the protein-of-interest comprises an Avitag sequence or a derivative thereof. 
     
     
         8 . The method of  claim 1 , wherein the protein-of-interest does not comprise an Avitag sequence or a derivative thereof. 
     
     
         9 . The method of  claim 1 , wherein the method further comprises adding a second linker molecule to form the electrical connection. 
     
     
         10 . The method of  claim 9 , wherein the second linker molecule comprises a streptavidin molecule. 
     
     
         11 . The method of  claim 10 , wherein the streptavidin molecule comprises at least two biotin binding sites. 
     
     
         12 . The method of  claim 1 , wherein the protein-of-interest comprises the least one non-canonical amino acid at two distinct locations. 
     
     
         13 . The method of  claim 12 , wherein the distinct locations comprise at least one of: (i) non-adjacent locations; (ii) locations that do not undergo substantial movement during protein activity; (iii) locations that are on an accessible surface of the protein-of-interest; and/or (iv) locations that are separated by at least 5 nm. 
     
     
         14 . The method of  claim 1 , wherein the protein-of-interest is selected from the group consisting of a polymerase, a nuclease, a proteasome, a glycopeptidase, a glycosidase, a kinase and an endonuclease. 
     
     
         15 . The method of  claim 1 , wherein the protein-of-interest is a polymerase. 
     
     
         16 . The method of  claim 15 , wherein exonuclease activity of the polymerase is disabled. 
     
     
         17 . A device for direct measurement of protein activity, the device comprising:
 a first electrode and a second electrode, wherein the first and second electrodes comprise surfaces chemically modified with at least one thiolated biotin linker molecule; and   a protein-of-interest that forms an electrical connection between the first and second electrodes comprising at least one non-canonical amino acid, wherein the at least one non-canonical amino acid comprises biotin or a derivative thereof;   wherein applying a voltage bias to the electrodes produces current flow through the protein-of-interest.   
     
     
         18 . The device of  claim 17 , wherein fluctuations in activity of the protein-of-interest correspond to fluctuations in current. 
     
     
         19 . The device of  claim 17 , wherein the at least one non-canonical amino acid is biocytin or a derivative thereof. 
     
     
         20 . The device of  claim 17 , wherein the protein-of-interest comprises two biocytin non-canonical amino acids or derivatives thereof. 
     
     
         21 . The device of  claim 17 , wherein the protein-of-interest comprises an Avitag sequence or a derivative thereof. 
     
     
         22 . The device of  claim 17 , wherein the protein-of-interest does not comprise an Avitag sequence or a derivative thereof. 
     
     
         23 . The device of  claim 17 , wherein the device further comprises a second linker molecule comprising a streptavidin molecule. 
     
     
         24 . The device of  claim 17 , wherein the protein-of-interest comprises the least one non-canonical amino acid at two distinct locations. 
     
     
         25 . The device of  claim 24 , wherein the distinct locations comprise at least one of: (i) non-adjacent locations; (ii) locations that do not undergo substantial movement during protein activity; (iii) locations that are on an accessible surface of the protein-of-interest; and/or (iv) locations that are separated by at least 5 nm. 
     
     
         26 . The device of  claim 17 , wherein the protein-of-interest is selected from the group consisting of a polymerase, a nuclease, a proteasome, a glycopeptidase, a glycosidase, a kinase and an endonuclease. 
     
     
         27 . The device of  claim 17 , wherein the protein-of-interest is a polymerase. 
     
     
         28 . The device of  claim 27 , wherein exonuclease activity of the polymerase is disabled. 
     
     
         29 . A system for direct electrical measurement of protein activity, the system comprising:
 the device of  claim 17 ;   a means for introducing a chemical entity that is capable of interacting with the protein-of-interest;   a means for applying a voltage bias between the first and second electrodes that is 100 mV or less; and   a means for monitoring fluctuations that occur as the chemical entity interacts with the protein-of-interest.

Join the waitlist — get patent alerts

Track US2022196646A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.